The capital raise, led by MonCap, is one of the most significant investments awarded in the space
Ryeqo, a drug aimed at relieving the symptoms associated with endometriosis, has been approved by Australia's drug regulator this week
Campaigners have called on employers to address the "culture of discomfort and ignorance" around periods
Clementine users are now able to access one-to-one support alongside their hypnotherapy sessions
The funding will be used to expand Elektra's care delivery platform across payers, self-insured employers and new markets
The Leeds-based group aims to build a diverse investment community for women entrepreneurs in the north of England
Oula plans to expand its hybrid care approach and launch new services for those in their reproductive years
The app aims to help women track and better understand their menopause symptoms
ShiraTronics will evaluate the performance of its minimally invasive migraine therapy in "pivotal" clinical study
Researchers will evaluate the safety and effectiveness of an antibody designed to reduce inflammation and endometriosis symptoms
